2007
DOI: 10.1159/000098400
|View full text |Cite
|
Sign up to set email alerts
|

How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?

Abstract: Background/Aims: Congenital adrenal hyperplasia (CAH) is increasingly being included in newborn screening programs. Screening can prevent neonatal mortality in children with salt-wasting CAH, but the number of deaths prevented is not known. Cost-effectiveness analyses of screening require estimates of the probability of mortality in CAH. Methods: We reviewed the literature to identify cohort studies of children with CAH ascertained clinically in the absence of screening. We abstracted the numbers of infant dea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
58
1
5

Year Published

2007
2007
2016
2016

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 73 publications
(68 citation statements)
references
References 88 publications
4
58
1
5
Order By: Relevance
“…The unrecognized and thus untreated disease may lead to life-threatening SW crisis in the newborn period (2). Neonatal screening for classical 21-OHD, which is now routinely performed in most western countries, has significantly reduced the number of SW crises in neonates and thereby mortality rates during infancy (2,3,4,5). However, patients with classical CAH are at risk of lifethreatening adrenal crisis (AC) during their entire life (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…The unrecognized and thus untreated disease may lead to life-threatening SW crisis in the newborn period (2). Neonatal screening for classical 21-OHD, which is now routinely performed in most western countries, has significantly reduced the number of SW crises in neonates and thereby mortality rates during infancy (2,3,4,5). However, patients with classical CAH are at risk of lifethreatening adrenal crisis (AC) during their entire life (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…(5) for metabolic disorders is not established even in teaching hospitals, this case serves as an example for mandatory screening in the second child when the first sibling is affected with CAH, which could prevent many deaths in the severe form. (6,7) …”
Section: Resultsmentioning
confidence: 99%
“…38 Available data from high-income countries indicate a low level of mortality associated with unscreened CAH, even taking into account the missed cases. 33,39 As a consequence, economic evaluations that use historical estimates of mortality associated with unscreened CAH will likely overestimate the cost-effectiveness of screening for CAH in such countries. 38 On the other hand, screening has benefits besides prevention of death, such as the prevention of morbidity.…”
Section: Clinical Outcomes For Individuals Identified Via Screening Vmentioning
confidence: 99%